Layoffs at Boundless Bio
- Layoff events
- 3
- verified and sourced
- Roles reported
- Not stated
- no source gives a number
- Announced between
- Aug 2024 to Jun 2026
- Reported by
- U.S. Securities and Exchange Commission, Boundless Bio, Boundless Bio / U.S. Securities and Exchange Commission, U.S. SEC, and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Boundless Bio: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Boundless Bio |
Merger or acquisition
Boundless Bio announced a workforce reduction of approximately 75% in connection with its merger agreement with Serapha Bio. |
Not known | 75% | Company-wide | ||
| Boundless Bio |
Restructuring
Boundless Bio announced a workforce reduction of approximately one-third as part of a portfolio-prioritization plan. |
Not known | Not known | Company-wide |
1 source for Boundless Bio |
|
| Boundless Bio |
Restructuring
Boundless Bio modestly reduced its workforce and discovery operations as enrollment in its first clinical-stage program progressed more slowly than expected. |
Not known | Not known | United States |
1 source for Boundless Bio |
Where this comes from
Every cut listed for Boundless Bio was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Boundless Bio? Tell us on our Discord and we will check it.